GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Change in Account Payables (2009 - 2010)

Updated

GT Biopharma's Change in Account Payables was -$23.08 million in Q3 2010, compared with $20 million a year earlier.

Analysis

GT Biopharma (GTBP) Change in Account Payables (2009 - 2010) Analysis & Trends

On a trailing twelve-month basis, GT Biopharma's Change in Account Payables was -$64.08 million through Sep 30, 2010; for FY2009, it was $5 million.

  • Quarterly Change in Account Payables has moved between -$64 million (Q4 2009) and $48 million (Q1 2009) over five years.
  • Per Business Quant data, GTBP's Change in Account Payables in the three quarters before Q3 2010 was $23.15 million (Q2 2010), -$151,000 (Q1 2010) and -$64 million (Q4 2009).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 254.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 GT Biopharma 6.65 Mn -16.58 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2010 -23.08 Mn
Jun 30, 2010 23.15 Mn
Mar 31, 2010 -151,000.00
Dec 31, 2009 -64.00 Mn
Sep 30, 2009 20.00 Mn
Jun 30, 2009 1.00 Mn
Mar 31, 2009 48.00 Mn
API Access

GT Biopharma Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=GTBP&period=max&api_key=YOUR_API_KEY